BAP1-Inactivated Melanocytic Tumors With Distinctive p16-Negative Clonal Growth and Liver Metastases
BAP1-inactivated melanocytic tumor (BIMT) represents a distinct subtype of melanocytoma, with characteristic morphologic features. These lesions are associated with inactivation of the BAP1 tumor suppressor gene. Although there are frequently histologic features that might otherwise cause concern for malignancy, including enlarged cells with nuclear variability, prominent nucleoli, and a lymphocytic inflammatory infiltrate, empirical data suggest that the majority behave in a clinically benign fashion. We report 2 cases of cutaneous BIMT with a distinctive morphologic pattern of clonal expansion with p16 loss. In both cases, there was liver metastasis after complete excision, in the absence of locoregional recurrence. These rare cases highlight the possibility of a distinct pathway of malignant progression in BIMT.
Authors
- Sarah Shepard
- Nima Mesbah Ardakani (ORCID: https://orcid.org/0000-0001-9477-8291)
- Nathan T. Harvey (ORCID: https://orcid.org/0000-0001-5253-976X)
- Benjamin A. Wood (ORCID: https://orcid.org/0000-0001-6336-0036)
- Craig James
Institutions
- South Australia Pathology (AU)
- The University of Western Australia (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- American Journal of Dermatopathology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1097/dad.0000000000003151
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00